Shares of Sun Pharmaceutical on Thursday lost up to 3.5% to hit the day’s low at Rs 981.50 in morning trade after the company told stock exchanges that its Halol facility in Gujarat had been placed under ‘Import Alert’ by USFDA.We now wish to inform you that the Company received a communication from the USFDA stating that the facility has been listed under Import Alert,” Sun Pharma said in a regulatory filing.
